J. Judice
Amministratore Delegato presso DICE THER
Posizioni attive di J. Judice
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| DICE THER | Fondatore | - | - |
| Amministratore Delegato | 01/08/2013 | - | |
| Direttore/Membro del Consiglio | - | - | |
DiCE Molecules, Inc.
 DiCE Molecules, Inc. Packaged SoftwareTechnology Services DiCE Molecules, Inc. is a private company that focuses on immunology and small molecule discovery. The company is based in Menlo Park, CA. The company's goal is to provide convenient oral medicines with biologic-like efficacy to patients with chronic diseases. The company was founded by J. Kevin Judice and he has been the CEO since incorporation. | Amministratore Delegato | - | - |
| Fondatore | - | - | |
| Presidente | - | - | |
DICE Molecules SV, Inc.
 DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Amministratore Delegato | 01/01/2013 | - |
| Fondatore | 01/01/2013 | - |
Storia della carriera di J. Judice
Precedenti posizioni note di J. Judice
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CIDARA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 30/06/2014 | 20/04/2015 |
| Direttore Tecnico/Scientifico/R&S | 30/06/2014 | - | |
| Fondatore | 01/12/2012 | 20/04/2015 | |
| ACHAOGEN | Direttore/Membro del Consiglio | 19/01/2011 | 01/10/2011 |
| Amministratore Delegato | 01/06/2002 | 01/10/2011 | |
| Direttore Tecnico/Scientifico/R&S | 01/06/2002 | 01/10/2011 | |
| Fondatore | 01/06/2002 | 07/03/2011 | |
| THERAVANCE BIOPHARMA, INC. | Corporate Officer/Principal | 01/09/1997 | 01/03/2002 |
| INNOVIVA, INC. | Corporate Officer/Principal | - | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Formazione di J. Judice
| University of California, Los Angeles | Doctorate Degree |
| Texas A&M University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 11 |
Posizioni
| Founder | 5 |
| Chief Executive Officer | 4 |
| Director/Board Member | 3 |
Settori
| Health Technology | 7 |
| Consumer Services | 3 |
| Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| CIDARA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
DiCE Molecules, Inc.
DiCE Molecules, Inc. Packaged SoftwareTechnology Services DiCE Molecules, Inc. is a private company that focuses on immunology and small molecule discovery. The company is based in Menlo Park, CA. The company's goal is to provide convenient oral medicines with biologic-like efficacy to patients with chronic diseases. The company was founded by J. Kevin Judice and he has been the CEO since incorporation. | Technology Services |
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology DiCE Therapeutics, Inc. is a biopharmaceutical company, which designs and develops a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was founded by J. Kevin Judice on August 14, 2013 and is headquartered in South San Francisco, CA. | Health Technology |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Finance |
- Borsa valori
- Insiders
- J. Judice
- Esperienza
